BNBX
BNB Plus Corp.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Clay D. Shorrock
IPO Date
2025-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
BNB Plus Corp.
CEO
Clay D. Shorrock
IPO Date
2025-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 77,038 |
| $0.69 |
| 31 Mar 2026 | Murrah Judith | director | A-Award | Acquired | 77,038 | $0.69 |
| 31 Mar 2026 | Ceccoli Joseph D. | director | A-Award | Acquired | 77,038 | $0.69 |
| 31 Mar 2026 | Kruger Joshua | director, other: Chairman of the Board | A-Award | Acquired | 77,038 | $0.69 |
| 31 Mar 2026 | Haft James | director | A-Award | Acquired | 77,038 | $0.69 |
| 13 Feb 2026 | Haft James | director | A-Award | Acquired | 80,730 | $1.31 |
| 13 Feb 2026 | Haft James | director | A-Award | Acquired | 12,270 | $1.31 |
| 13 Feb 2026 | Haft James | director | Disposed | 0 | $0.00 |
| 16 Dec 2025 | Shorrock Clay | Chief Executive Officer | A-Award | Acquired | 42,194 | $2.52 |